Rosuvastax 5 mg
Rosuvastax 5 mg is a medicine authorised by Swissmedic under authorisation number 66447. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 June 2017 and the authorisation is valid without a time limit. ATC code C10AA07 places the medicine in the group Lipid modifying agents.
| Authorisation number | 66447 |
|---|---|
| Name | Rosuvastax 5 mg |
| Full name | Rosuvastax 5 mg, Filmtabletten |
| Authorisation holder | Drossapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C10AA07 |
| First authorisation | 28 June 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rosuvastax 5 mg, Filmtabletten | B | 28 June 2017 |
| 2 | Rosuvastax 10 mg, Filmtabletten | B | 28 June 2017 |
| 3 | Rosuvastax 20 mg, Filmtabletten | B | 28 June 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 2 | 100 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 3 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 4 | 100 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 5 | 30 | Tablette(n) | C10AA07 | 07.12.0. | B |
| 6 | 100 | Tablette(n) | C10AA07 | 07.12.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rosuvastax 5 mg authorised in Switzerland?
Yes. Rosuvastax 5 mg is authorised by Swissmedic under authorisation number 66447, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rosuvastax 5 mg have?
Rosuvastax 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rosuvastax 5 mg?
The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.